首页 › 基金 › AMI ASSET MANAGEMENT CORP › ARQT

AMI ASSET MANAGEMENT CORP 对 ARQT 的持仓历史

ARCUTIS BIOTHERAPEUTICS INC · 医疗保健

AMI ASSET MANAGEMENT CORP 在 Q3 2026 的 13F 申报中披露持有 ARQT(ARCUTIS BIOTHERAPEUTICS INC)41,505 股,市值约 US$1.1M,约占其申报组合的 0.07%,在其申报持仓中市值排名第 42 位。 AMI ASSET MANAGEMENT CORP 最近 11 个申报季度中有 11 个季度披露了 ARQT 持仓,最早可追溯至 Q1 2024。

最新持仓 (Q3 2026)41.51K 股
申报持仓市值$1.10M
组合权重0.07%
首次申报Q1 2024
最近变动增持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

AMI ASSET MANAGEMENT CORP 对 ARQT 的持仓演变

AMI ASSET MANAGEMENT CORP 于 Q1 2024 首次披露 ARQT 持仓:345,239 股(约 US$3.4M)。 在 11 次申报中,AMI ASSET MANAGEMENT CORP 3 次增持、7 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 41,505 股、市值约 US$1.1M,环比增持 4,384 股。。 持仓曾出现大幅变动:Q2 2024 减持约 52% (随后一个季度股价基本持平)、Q2 2025 减持约 45% (随后一个季度股价上涨 34%)、Q4 2025 减持约 49% (随后一个季度股价下跌 19%)。

逐季持仓明细

季度股数金额变化
Q1 2024 345.24K $3.42M 新进
Q2 2024 164.19K $1.53M 减持
Q3 2024 223.68K $2.08M 增持
Q4 2024 215.96K $3.01M 减持
Q1 2025 208.72K $3.26M 减持
Q2 2025 113.88K $1.60M 减持
Q3 2025 96.09K $1.81M 减持
Q4 2025 49.26K $1.43M 减持
Q1 2026 50.86K $1.20M 增持
Q2 2026 37.12K $973.31K 减持
Q3 2026 41.51K $1.10M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ARQT 与 13F 数据

ARQT(ARCUTIS BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 ARQT,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$326.1M), Frazier Life Sciences Management, L.P. (US$258.9M), Rubric Capital Management LP (US$216.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ARQT 的基金

查看 ARQT 的全部基金持有人 →

常见问题

How long has AMI ASSET MANAGEMENT CORP held ARQT?

AMI ASSET MANAGEMENT CORP has disclosed ARQT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is AMI ASSET MANAGEMENT CORP's current position in ARQT?

As of Q3 2026, AMI ASSET MANAGEMENT CORP holds 41.51K shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), valued at $1.10M, representing 0.07% of its reported portfolio and ranking #42.

Has AMI ASSET MANAGEMENT CORP been buying or selling ARQT?

In the latest 13F filing (Q3 2026), AMI ASSET MANAGEMENT CORP increased its position in ARQT.

Which other funds hold ARQT?

Other major institutional holders of ARQT include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.